Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

733 ARTÍCULOS , VIENDO DEL 31 AL 45

Sleep Spindles and Slow Oscillations as Potential Biomarkers and Therapeutic Targets in Mild-to-Moderate Alzheimer's Disease

Páez A, Piñol-Ripoll G, Dakterzada F, Dang-Vu TT.

Curr Neurol Neurosci Rep. 2026 Oct 20;26(1):58. doi: 10.1007/s11910-026-01528-9.

Andrographolide: Mechanisms and Therapeutic Potential in Alzheimer's and Parkinson's Disease

Ríos-Gallardo A, Herrera-Ramirez D, Bastias-Candia S, Inestrosa NC.

Molecules. 2026 Sep 8;31(18):3139. doi: 10.3390/molecules31183139.

Recent developments in donepezil-based hybrid molecules as multi-target therapeutics for Alzheimer's disease: A paradigm shift beyond symptomatic treatment

Kumar N, Khan I, Singh J, Kumar K, Kushwaha VK, Ojha S, Raman SK, Shankar G.

Bioorg Chem. 2026 Oct 5;181:110361. doi: 10.1016/j.bioorg.2026.110361. Epub 2026 Aug 10.

Anatomy of a Setback: A Taxonomy of Clinical Trial Failures in Alzheimer's Disease and Strategic Lessons for the Future

Emanuele E, Minoretti P.

FASEB J. 2026 Aug 31;40(16):e72221. doi: 10.1096/fj.202601680RR.

Xanthones and Their Nitrogen and Sulfur Analogs in Alzheimer's Disease: Recent Progress Toward Multifunctional Therapeutics

Malafaia D, Melo L, Silva AMS, Albuquerque HMT.

ChemMedChem. 2026 Aug 27;21(16):e70453. doi: 10.1002/cmdc.70453.

Trehalose's untapped mechanisms in alzheimer's: gut-brain-autophagy signalling beyond the usual targets

Gunasekaran SK, K HKC, Gobinath M, Roychowdhury P, N MS.

Daru. 2026 Aug 31;34(2):65. doi: 10.1007/s40199-026-00647-5.

Novel Therapeutic Insights Into Alzheimer's Disease: Glymphatic System and Meningeal Lymphatic Vessels

Song B, Wang W, Liu S, Jin X, Qi Y, Li M, Yue D, Liu Y, Li X, Yin L, Feng L.

Aging Cell. 2026 Sep;25(9):e70699. doi: 10.1111/acel.70699.

Quercetin-Based Nanotherapeutics for Targeted Drug Delivery in Alzheimer's Disease: Comparative Insights into Molecular Mechanisms, Blood-Brain Barrier Targeting and Therapeutic Perspectives

Begum MY, Rajkumar M, Govindaraj P, Velmani S, Rajkumar P, Sudha PN, Alhamod M, Alotaibi H.

Mol Neurobiol. 2026 Sep 16;63(1):900. doi: 10.1007/s12035-026-06188-x.

Targeting the BACE1-GSK-3β Signaling Axis in Alzheimer's Disease: From Molecular Crosstalk to Nanotechnology-Based Translational Strategies

Marimuthu A, Singh MT, Balasubramanian S, Krishnamurthy PT.

Mol Neurobiol. 2026 Sep 21;63(1):909. doi: 10.1007/s12035-026-06203-1.

Investigating the therapeutic potential of 1,2,3,4,6 penta-O-galloyl-β-D-glucose in Alzheimer's disease: a scoping review

Kahil E, Jackson A, D'Souza B, Gorman G, Jumbo-Lucioni P.

Nat Prod Res. 2026 Sep;40(17):5437-5451. doi: 10.1080/14786419.2025.2477226. Epub 2025 Mar 17.

Evaluating emerging amyloid-β centric drugs for the treatment of Alzheimer's disease

Lozupone M, Dibello V, Sardone R, Zupo R, Castellana F, Bortone I, Lampignano L, Di Matteo M, Moramarco G, Dellegrazie F, Daniele A, Solfrizzi V, Panza F.

Expert Opin Emerg Drugs. 2026 Sep;31(3):107-121. doi: 10.1080/14728214.2026.2693701. Epub 2026 Jun 30.

Apolipoprotein E in Alzheimer's disease: A review of APOE receptors, signalling pathways and therapeutic opportunities

Jayaram S, Easwaran V, Selvaraj D, Gunasekaran V, Soumya V, Thiruselvi M, Laxmana Prasanth M, Singh S, Ellaiyarasu C, Karthik Rai P, Gokula Priyan G, Thahideen A, Sabarieshwaran K.

Mol Cell Neurosci. 2026 Sep;138:104108. doi: 10.1016/j.mcn.2026.104108. Epub 2026 Jun 26.

Regulation of NLRP3 inflammasome signaling in Alzheimer's disease: emerging neuroprotective role of phytochemicals

Gupta A, Singh S, Singh TD.

Inflammopharmacology. 2026 Aug;34(8):5343-5363. doi: 10.1007/s10787-026-02324-0. Epub 2026 Jul 8.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias